YY/T 1524-2017alpha-L-Fucosidase (AFU) assay kit (CNPF substrate method) (English PDF)
α-L-岩藻糖苷酶(AFU)测定试剂盒(CNPF底物法)
This is a limited preview
Buy now to download the full PDF (21 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1524-2017 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
March 28, 2017
Implementation date
April 1, 2018
Scope
YY/T 1524-2017 is the English-translated version of α-L-岩藻糖苷酶(AFU)测定试剂盒(CNPF底物法).
YY/T 1524-2017 is the Chinese pharmaceutical industry standard for the alpha-L-fucosidase assay kit based on the CNPF substrate method.
It sets the requirements, the test methods, the label and instructions for use and the rules for packaging, transport and storage, covering the appearance, the blank absorbance, analytical sensitivity, linearity, precision, accuracy and stability.
It applies to kits that measure the enzyme activity quantitatively in human serum or plasma. Issued on 28 March 2017, it has applied since 1 April 2018.
Found what you need?
Document preview — YY/T 1524-2017
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- 1 Scope4
- 2 Normative References4
- 3 Requirements4
- 4 Test Methods6
- 5 Label and Use Instructions10
- 6 Package, Transportation and Storage10
- Bibliography11
1 Scope
This Standard specifies the requirements, test methods, label and use instructions, package, transportation and storage of alpha-L-fucosidase (AFU) assay kit.
This Standard is applicable to reagent (kit) (hereinafter referred to as kit) performing quantitative detection by CNPF (2-chloro-4-nitrophenyl-alpha-L-fucoylpyranoside) substrate method against the alpha-L-fucosidase in human serum or plasma; including the reagents used on the manual and semi-automatic, fully automated biochemical analyzers.
2 Normative References
The following documents are essential to the application of this document. For the dated documents, only the versions with the dates indicated are applicable to this document; for the undated documents, only the latest version (including all the amendments) are applicable to this document.
GB/T 29791.2 In Vitro Diagnostic Medical Devices - Information Supplied by the Manufacturer (Labelling) - Part 2. In Vitro Diagnostic Reagents for Professional
3 Requirements
3.1 Appearance
The appearance of kit shall meet the following requirements.
a) The components of kit shall be complete and intact; there is no liquid leakage;
b) The text and symbols of package label shall be clear.
3.2 Loading amount
It shall be no less than the marked value.
4 Test Methods
4.2 Appearance
Take visual examination with normal or corrected visual acuity under natural light, the results shall meet the requirements of 3.1.
4.3 Loading amount
Use general measuring gauge to measure; it shall meet the requirements of 3.2.
4.4 Reagent blank
4.4.1 Reagent blank absorbance
Use reagent kit to test the blank sample; record the absorbance value (A) at the dominant wavelength of the reading point specified in the reagent kit parameters; which shall meet the requirements of 3.3.1.
4.4.2 Reagent blank absorbance change rate
Test the blank sample with kit; record the absorbance value (A) of the reading point specified in the kit parameters; calculate the absorbance change rate (deltaA/min), which shall meet the requirements of 3.3.2.
NOTE. The blank sample can be pure water sample, saline, zero calibration solution, and the like.
4.5 Analytical sensitivity
Test the sample with a known concentration (30±10) U/L of alpha-L-fucosidase by a kit; record the absorbance value (A) at the reading point specified in the kit parameters; convert into 30 U/L sample's absorbance change rate (deltaA/min), which shall meet the requirements of 3.4.
4.6 Linear
4.6.1 Use the low-concentration sample near the lower limit of the linear interval to dilute the high-concentration sample near the upper limit of the linear interval; mix into at least 5 dilution concentrations (xi). Use kit to separately test the above samples; each dilution concentration shall be tested for 3 times; separately calculate the mean value (yi) of each dilution concentration test results. Obtain the linear regression equation by taking the dilution concentration (xi) as the independent variable and the mean value of test result (yi) as the dependent variable. Calculate the correlation coefficient (r) of the linear regression, which shall meet the requirements of 3.5a).
4.6.2 Substitute the dilution concentration (xi) of the 4.6.1 method into the linear regression equation; calculate the relative deviation or absolute deviation between yi test mean and the corresponding estimate, which shall meet the requirements of 3.5b).
4.8.2 Relative deviation
The kit test can be used to evaluate a certified reference material (CRM) of conventional method or other recognized reference materials for 3 times; the test results can be recorded as (Xi); separately calculate the relative deviation (B) as per Formula (4); if all the 3 results meet the requirements of 3.7a), then it can be judged qualified. If the result of greater than or equal to 2 times are not qualified, then it is judged disqualified. If one result does not meet the requirements, then retest for 20 times; separately calculate the relative deviation as per the Formula (4); if the results of greater than or equal to 19 times meet the requirements of 3.7a), then the accuracy shall meet the requirements of 3.7a). Where. Bi - relative deviation; Xi - measurement concentration; T - calibrated concentration of reference material.
4.8.3 Enterprise reference product test
The manufacturer shall provide the enterprise reference product; test according to the routine sample; each sample shall be tested for 3 times; calculate the average value of the measurement results, which shall meet the requirements of 3.7b).
4.8.4 Comparison test
Use no less than 40 human samples of different concentrations within the detection concentration range to conduct a comparison test with a traceable analysis system designated by the manufacturer. Each sample shall be tested according to the requirements of to-be-tested kit and selected analysis system; each sample shall be tested once; use the linear regression method to linearly fit the two sets of results; then obtain the correlation coefficient (r) and slope of linear regression equation; calculate the absolute deviation or relative deviation between the measured value of the to-be-tested kit and the measured value of control system for each sample, which shall meet the requirements of 3.7c).
4.9 Stability
4.9.1 Shelf life stability
Take the sample after the expiration date, test as per the method specified in 4.4, 4.5, 4.6, 4.7.1, 4.8, which shall meet the requirements of 3.8.2.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 21 pages — is available in the English PDF.
Referenced standards
Similar standards
How to Download YY/T 1524-2017
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 29791.2-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 2: In vitro diagnostic reagents for professional use
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
YY/T 0479-2026 — Medical diagnostic X-ray tube assemblies and X-ray source assemblies - Determination of maximum symmetric radiation field
Secure payment via Stripe
Payments accepted
YY/T 1524-2017
$125.00